A Rare Case of Combined Rocuronium Induced Malignant Hyperthermia and Propofol-Induced Lactic Acidosis

Mohamedanwar Ghandour^1, , Heba Osman², Samer Alkassis³, Zeenat Y. Bhat⁴ and Yahya Osman-Malik⁴

¹Department of Internal Medicine, Nephrology division, Wayne State University/Detroit Medical Center, Michigan, USA

²Department of Internal Medicine/Pediatrics, Wayne State University/Detroit Medical Center, Michigan, USA

³Department of Internal Medicine, Wayne State University/Detroit Medical Center, Michigan, USA

⁴Department of Internal Medicine WSU SOM, Division of Nephrology Wayne State University, Michigan, USA

Cite this paper:
Mohamedanwar Ghandour, Heba Osman, Samer Alkassis, Zeenat Y. Bhat and Yahya Osman-Malik. A Rare Case of Combined Rocuronium Induced Malignant Hyperthermia and Propofol-Induced Lactic Acidosis. American Journal of Medical Case Reports. 2021; 9(3):206-207. doi: 10.12691/ajmcr-9-3-18

Abstract

We report an unusual case of A 64-year-old female received rocuronium and propofol and subsequently developed malignant hyperthermia and particularly propofol-related infusion syndrome.

Keywords:

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issues. 2004; 15: 231-7.
[2]	Nelson TE. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med. 2002; 2: 347-69.
[3]	Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2011; 1813:948.
[4]	Cully TR, Choi RH, Bjorksten AR, et al. Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation. Proc Natl Acad Sci U S A 2018; 115: 8215.
[5]	Hatch DJ. Propofol-infusion in children. Lancet 1999; 353: 1117-8.
[6]	Van Straaten EA, Hendriks JJE, Ramsey G, Vos GD. Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion. Intensive Care Medicine 1996; 22: 997.
[7]	Cremer OL, Moons KGM, Bouman EAC, Kruijswijk JE, De Smet AMGA, Kalkman CJ. Long term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-8.
[8]	Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Critical Care Medicine 2000; 28: 3071-4.
[9]	Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007; 62(7): 690-701.
[10]	Propofol (Diprivan) bivirkninger [Adverse effects of propofol (Diprivan)]. Ugeskr Laeger. 1990; 152(16): 1176.
[11]	Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019; 122(4): 448-459.
[12]	Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. British Journal of Anaesthesia. 2019; 122(4): 448-459.
[13]	Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol. 2010; 23: 417-22.
[14]	Rosero EB, Adesanya AO, Timaran CH et al. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology. 2009; 110: 89-94.
[15]	Prabhu M, Samra S. An unusual cause of rhabdomyolysis following surgery in the prone position. J Neurosurg Anesthesiol. 2000; 12: 359-63.